Conference
Abstract P6-09-30: Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with Trastuzumab
Abstract
Abstract
Background: We have limited capability to predict survival among patients treated for metastatic HER2+ breast cancer. Individual patient survival varies and further research is warranted to identify significant prognostic and predictive factors influencing overall survival (OS).
Authors
Blanchette P; Desautels D; Pond G; Bartlett J; Nofech-Mozes S; Yaffe M; Pritchard K
Volume
77
Publisher
American Association for Cancer Research (AACR)
Publication Date
February 15, 2017
DOI
10.1158/1538-7445.sabcs16-p6-09-30
Conference proceedings
Cancer Research
Issue
4_Supplement
ISSN
0008-5472